Clinical Trial Update: Sertraline for the Prevention of Recurrent Postpartum Depression [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sertraline to prevent recurrence of postpartum depression has completed; the snippet does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Postpartum Depression

Drugs mentioned

• Sertraline (Sertraline)

Snippet

Sponsor: University of Pittsburgh | Conditions: Depression | Phase 3 | Status: COMPLETED